# Phase I/II Study of AloCelyvir in Patients With Metastatic Uveal Melanoma

> **NCT05047276** · PHASE1,PHASE2 · UNKNOWN · sponsor: **José María Piulats Rodríguez** · enrollment: 16 (estimated)

## Conditions studied

- Uveal Melanoma, Metastatic

## Interventions

- **BIOLOGICAL:** AloCelyvir

## Key facts

- **NCT ID:** NCT05047276
- **Lead sponsor:** José María Piulats Rodríguez
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-01
- **Primary completion:** 2023-06-30
- **Final completion:** 2024-12-31
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2021-09-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05047276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05047276, "Phase I/II Study of AloCelyvir in Patients With Metastatic Uveal Melanoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05047276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*